# ADDYI

NDC: 58604-214
Generic name: flibanserin
Labeler / Manufacturer: Sprout Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20150818

FDA application: NDA022526

## Active ingredients

- FLIBANSERIN: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58604-214"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58604-214
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3819daf3-e935-2c53-c527-e1d57922f394